Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) Group.
Kamal K, Xia E, Li SJ, Alavi A, Cogen AL, Firooz A, Marzano AV, Kaffenberger BH, Sibbald C, Fernandez AP, Callen JP, Dissemond J, Gontijo JRV, Shams K, Gerbens LA, French LE, Gould LJ, Bissonnette R, Shaigany S, Tolkachjov S, Yamamoto T, Wei-Ting Huang W, Ortega-Loayza AG, Mostaghimi A. Kamal K, et al. Among authors: kaffenberger bh. J Invest Dermatol. 2024 Jun;144(6):1295-1300.e6. doi: 10.1016/j.jid.2023.12.006. Epub 2023 Dec 16. J Invest Dermatol. 2024. PMID: 38110114
Diagnosis uPGrade-Advances in Pyoderma Gangrenosum.
Kaffenberger BH, Trinidad J. Kaffenberger BH, et al. JAMA Dermatol. 2018 Apr 1;154(4):397-398. doi: 10.1001/jamadermatol.2017.5979. JAMA Dermatol. 2018. PMID: 29450448 No abstract available.
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States.
Micheletti RG, Chiesa-Fuxench Z, Noe MH, Stephen S, Aleshin M, Agarwal A, Boggs J, Cardones AR, Chen JK, Cotliar J, Davis MDP, Dominguez A, Fox LP, Gordon S, Hamrick R, Ho B, Hughey LC, Jones LM, Kaffenberger BH, Kindley K, Kroshinsky D, Kwong BY, Miller DD, Mostaghimi A, Musiek A, Ortega-Loayza AG, Patel R, Posligua A, Rani M, Saluja S, Sharon VR, Shinkai K, John JS, Strickland N, Summers EM, Sun N, Wanat KA, Wetter DA, Worswick S, Yang C, Margolis DJ, Gelfand JM, Rosenbach M. Micheletti RG, et al. Among authors: kaffenberger bh. J Invest Dermatol. 2018 Nov;138(11):2315-2321. doi: 10.1016/j.jid.2018.04.027. Epub 2018 Jul 27. J Invest Dermatol. 2018. PMID: 29758282 Free article.
Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.
Noe MH, Rosenbach M, Hubbard RA, Mostaghimi A, Cardones AR, Chen JK, Cotliar J, Davis MDP, Dominguez A, Fox LP, Hughey LC, Kaffenberger BH, Kroshinsky D, Kwong BY, Miller DD, Musiek A, Ortega-Loayza AG, Sharon VR, Shinkai K, Summers EM, Wanat KA, Wetter DA, Worswick S, Margolis DJ, Gelfand JM, Micheletti RG. Noe MH, et al. Among authors: kaffenberger bh. JAMA Dermatol. 2019 Apr 1;155(4):448-454. doi: 10.1001/jamadermatol.2018.5605. JAMA Dermatol. 2019. PMID: 30840032 Free PMC article.
A survey-based study of diagnostic and treatment concordance in standardized cases of cellulitis and pseudocellulitis via teledermatology.
Korman AM, Kroshinsky D, Raff AB, Mostaghimi A, Micheletti RG, Rosenbach M, Kaffenberger BH; Society of Dermatology Hospitalists Scientific Task Force on Cellulitis. Korman AM, et al. Among authors: kaffenberger bh. J Am Acad Dermatol. 2020 May;82(5):1221-1223. doi: 10.1016/j.jaad.2019.09.084. Epub 2019 Oct 15. J Am Acad Dermatol. 2020. PMID: 31626887 No abstract available.
Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults.
Seminario-Vidal L, Kroshinsky D, Malachowski SJ, Sun J, Markova A, Beachkofsky TM, Kaffenberger BH, Ergen EN, Mauskar M, Bridges A, Calhoun C, Cardones AR, Chen ST, Chodosh J, Cotliar J, Davis MDP, DeNiro KL, Dominguez AR, Eljure-Téllez J, Femia A, Fox LP, Guda A, Mitchell C, Mostaghimi A, Ortega-Loayza AG, Owen C, Pasieka H, Rahnama-Moghadam S, Saeed HN, Saunderson RB, Shanbhag S, Sharon VR, Strowd L, Venkatesh S, Wanat KA, Wetter DA, Worswick S, Micheletti RG. Seminario-Vidal L, et al. Among authors: kaffenberger bh. J Am Acad Dermatol. 2020 Jun;82(6):1553-1567. doi: 10.1016/j.jaad.2020.02.066. Epub 2020 Mar 7. J Am Acad Dermatol. 2020. PMID: 32151629 Free article.
Use of teledermatology by dermatology hospitalists is effective in the diagnosis and management of inpatient disease.
Gabel CK, Nguyen E, Karmouta R, Liu KJ, Zhou G, Alloo A, Arakaki R, Balagula Y, Bridges AG, Cowen EW, Davis MDP, Femia A, Harp J, Kaffenberger B, Keller JJ, Kwong BY, Markova A, Mauskar M, Micheletti R, Mostaghimi A, Pierson J, Rosenbach M, Schwager Z, Seminario-Vidal L, Sharon VR, Song PI, Strowd LC, Walls AC, Wanat KA, Wetter DA, Worswick S, Ziemer C, Kvedar J, Mikailov A, Kroshinsky D. Gabel CK, et al. J Am Acad Dermatol. 2021 Jun;84(6):1547-1553. doi: 10.1016/j.jaad.2020.04.171. Epub 2020 May 7. J Am Acad Dermatol. 2021. PMID: 32389716 Free PMC article.
Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus.
Brüggen MC, Le ST, Walsh S, Toussi A, de Prost N, Ranki A, Didona B, Colin A, Horváth B, Brezinova E, Milpied B, Moss C, Bodemer C, Meyersburg D, Salavastru C, Tiplica GS, Howard E, Bequignon E, Bouwes Bavinck JN, Newman J, Gueudry J, Nägeli M, Zaghbib K, Pallesen K, Bygum A, Joly P, Wolkenstein P, Chua SL, Le Floch R, Shear NH, Chu CY, Hama N, Abe R, Chung WH, Shiohara T, Ardern-Jones M, Romanelli P, Phillips EJ, Stern RS, Cotliar J, Micheletti RG, Brassard A, Schulz JT, Dodiuk-Gad RP, Dominguez AR, Paller AS, Seminario-Vidal L, Mostaghimi A, Noe MH, Worswick S, Tartar D, Sheridan R, Kaffenberger BH, Shinkai K, Maverakis E, French LE, Ingen-Housz-Oro S. Brüggen MC, et al. Among authors: kaffenberger bh. Br J Dermatol. 2021 Sep;185(3):616-626. doi: 10.1111/bjd.19893. Epub 2021 Apr 27. Br J Dermatol. 2021. PMID: 33657677
Ustekinumab as adjuvant treatment for all pyoderma gangrenosum subtypes.
Westerdahl JS, Nusbaum KB, Chung CG, Kaffenberger BH, Ortega-Loayza AG. Westerdahl JS, et al. Among authors: kaffenberger bh. J Dermatolog Treat. 2022 Jun;33(4):2386-2390. doi: 10.1080/09546634.2021.1937475. Epub 2021 Jun 14. J Dermatolog Treat. 2022. PMID: 34057010 No abstract available.
224 results